Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients

Blood Cancer J. 2022 Jan 25;12(1):12. doi: 10.1038/s41408-022-00612-w.

¹ Division of Hematopathology, Mayo Clinic College of Medicine, Rochester, MN, USA. He.Rong@mayo.edu.
² Dartmouth College, Hanover, NH, USA.
³ Wellesley College, Wellesley, MA, USA.
⁴ Division of Hematopathology, Mayo Clinic College of Medicine, Rochester, MN, USA.
⁵ College of Science, University of Notre Dame, Notre Dame, IN, USA.
⁶ School of Medicine, University of Nebraska, Omaha, NE, USA.
⁷ Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN, USA.

^# Contributed equally.

No abstract available

Publication types